Japan’s Pharmaceuticals and Medical Devices Act separates cosmetics from a second class of quasi-pharmaceutical products, defined as items with mild effects on the human body used for certain listed purposes, and a person who intends to market a quasi-pharmaceutical product must obtain the approval of the Minister of Health, Labour and Welfare for each item.
Deodorant, anti-hair-loss and depilatory products cross a legal line in Japan that they do not cross in the United States, so a range that ships as one catalogue at home arrives as two regulatory workstreams with different lead times.